Humacyte is cutting costs to conserve cash as it tries to build momentum for its new product. But its stock is down more than 60 percent this... — read more
May 7th Layoffs
Today there was a 20% reduction at the Durham site. This was due to low sells of their products
Mgmt expects delay in FDA approval
Insiders learned that FDA not satisfied with BLA application and is delaying it's decision, so no approval in August and layoffs anticipated for recent hires. Very disappointing.